Please use this identifier to cite or link to this item:
https://doi.org/10.1155/2011/258797
DC Field | Value | |
---|---|---|
dc.title | Role of radiotherapy in modern treatment of Hodgkin's Lymphoma | |
dc.contributor.author | Yeoh, K.-W | |
dc.contributor.author | Mikhaeel, N.G | |
dc.date.accessioned | 2020-10-20T08:15:00Z | |
dc.date.available | 2020-10-20T08:15:00Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Yeoh, K.-W, Mikhaeel, N.G (2011). Role of radiotherapy in modern treatment of Hodgkin's Lymphoma. Advances in Hematology 2011 : 258797. ScholarBank@NUS Repository. https://doi.org/10.1155/2011/258797 | |
dc.identifier.issn | 1687-9104 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/178182 | |
dc.description.abstract | Hodgkin's Lymphoma was incurable until the advent of effective therapeutic radiation around the first half of the 20th century. As survival rates improved, the long-term toxicities from radiotherapy began to emerge. This together with the availability of effective chemotherapy has encouraged a combined modality approach for early-staged disease and the omission of radiotherapy in advanced-staged disease. The differing toxicities of radiotherapy and chemotherapy has promoted ongoing research to identify the utility of each of these modalities in the modern management of Hodgkin's Lymphoma. This article will provide a critical review of the developments and indications for modern radiotherapy, in context with advances in chemotherapy, for the treatment of Hodgkin's Lymphoma. Copyright © 2011 Kheng-Wei Yeoh and N. George Mikhaeel. | |
dc.publisher | Hindawi | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | advanced cancer | |
dc.subject | cancer radiotherapy | |
dc.subject | cancer survival | |
dc.subject | dosimetry | |
dc.subject | Hodgkin disease | |
dc.subject | human | |
dc.subject | practice guideline | |
dc.subject | priority journal | |
dc.subject | radiation dose | |
dc.subject | review | |
dc.subject | risk factor | |
dc.subject | salvage therapy | |
dc.subject | tumor volume | |
dc.type | Review | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.1155/2011/258797 | |
dc.description.sourcetitle | Advances in Hematology | |
dc.description.volume | 2011 | |
dc.description.page | 258797 | |
dc.published.state | published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1155_2011_258797.pdf | 1.19 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License